277 related articles for article (PubMed ID: 12524437)
21. Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces.
Zhu S; Lu Y; Sinno T; Diamond SL
J Biol Chem; 2016 Oct; 291(44):23027-23035. PubMed ID: 27605669
[TBL] [Abstract][Full Text] [Related]
22. Effects of platelets activated by different agonists on fibrin formation and thrombin generation.
Muravlev IA; Dobrovolsky AB; Antonova OA; Khaspekova SG; Mazurov AV
Platelets; 2023 Dec; 34(1):2139365. PubMed ID: 36325627
[TBL] [Abstract][Full Text] [Related]
23. Fibrin Modulates Shear-Induced NETosis in Sterile Occlusive Thrombi Formed under Haemodynamic Flow.
Yu X; Diamond SL
Thromb Haemost; 2019 Apr; 119(4):586-593. PubMed ID: 30722079
[TBL] [Abstract][Full Text] [Related]
24. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
Car BD; Baggiolini M; Walz A
Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
[TBL] [Abstract][Full Text] [Related]
25. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
26. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation.
Plescia J; Altieri DC
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):873-9. PubMed ID: 8920993
[TBL] [Abstract][Full Text] [Related]
27. Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration.
Hermant B; Bibert S; Concord E; Dublet B; Weidenhaupt M; Vernet T; Gulino-Debrac D
J Biol Chem; 2003 Apr; 278(16):14002-12. PubMed ID: 12584200
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil interaction with the hemostatic system contributes to liver injury in rats cotreated with lipopolysaccharide and ranitidine.
Deng X; Luyendyk JP; Zou W; Lu J; Malle E; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2007 Aug; 322(2):852-61. PubMed ID: 17505017
[TBL] [Abstract][Full Text] [Related]
29. Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets.
Cohen AB; Stevens MD; Miller EJ; Atkinson MA; Mullenbach G
Am J Physiol; 1992 Aug; 263(2 Pt 1):L249-56. PubMed ID: 1387511
[TBL] [Abstract][Full Text] [Related]
30. Inhibition by human leukocyte elastase of neutrophil-mediated platelet activation.
Renesto P; Balloy V; Chignard M
Eur J Pharmacol; 1993 Aug; 248(2):151-5. PubMed ID: 8223961
[TBL] [Abstract][Full Text] [Related]
31. Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions.
Kirchhofer D; Sakariassen KS; Clozel M; Tschopp TB; Hadváry P; Nemerson Y; Baumgartner HR
Blood; 1993 Apr; 81(8):2050-8. PubMed ID: 8097120
[TBL] [Abstract][Full Text] [Related]
32. Platelets provide robustness of spatial blood coagulation to the variation of initial conditions.
Balandina AN; Koltsova EM; Shibeko AM; Kuprash AD; Budkova VA; Demina IA; Ignatova AA; Fadeeva OA; Vijay R; Nair SC; Srivastava A; Shi Q; Ataullakhanov FI; Panteleev MA
Thromb Res; 2023 Oct; 230():133-143. PubMed ID: 37717370
[TBL] [Abstract][Full Text] [Related]
33. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M
Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
[TBL] [Abstract][Full Text] [Related]
34. Thrombin contributes to protective immunity in pneumonia-derived sepsis via fibrin polymerization and platelet-neutrophil interactions.
Claushuis TA; de Stoppelaar SF; Stroo I; Roelofs JJ; Ottenhoff R; van der Poll T; Van't Veer C
J Thromb Haemost; 2017 Apr; 15(4):744-757. PubMed ID: 28092405
[TBL] [Abstract][Full Text] [Related]
35. Unstimulated and thrombin-stimulated platelets binding to immobilized fibrinogen and fibrin on polystyrene supports.
Martínez-Sales V; Vila V; Réganon E; Aznar J
Haemostasis; 1995; 25(4):158-65. PubMed ID: 7557654
[TBL] [Abstract][Full Text] [Related]
36. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
[TBL] [Abstract][Full Text] [Related]
37. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
[TBL] [Abstract][Full Text] [Related]
38. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.
Zhu S; Chen J; Diamond SL
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1528-1536. PubMed ID: 29724819
[TBL] [Abstract][Full Text] [Related]
39. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
40. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
Janusz MJ; Doherty NS
J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
